Term ends Jul 26, 2030 · High confidence
20-year base term ends Jul 26, 2030
Held by Roche Molecular Systems, Inc.
Filed Apr 15, 2013 as application 13/862,530 · Granted May 24, 2016
Base term plus 69 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2010
2030
Clock starts
Jul 26, 2010
Jul 26, 2010
Term ends
Jul 26, 2030
Jul 26, 2030
Granted
May 24, 2016
May 24, 2016
base term
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
69
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 8,445,206, US 9,347,091.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 69 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jul 26, 2010, when application PCT/EP2010/004570, the earliest non-provisional in its chain, was filed (this one was filed Apr 15, 2013) | Jul 26, 2030 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +69 days, USPTO patent term adjustment record | Oct 3, 2030 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,445,206, US 9,347,091) | capped to Jul 26, 2030 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jul 26, 2030 | High confidence |
This family
| US 8,445,206 | In force Jul 2030 | Jul 2030 |
| US 9,347,091 | this patent Jul 2030 | Jul 2030 |
| US 10,640,815 | In force Mar 2031 | Mar 2031 |
| US 11,421,266 | In force Oct 2030 | Oct 2030 |
| Application 17/865,159 | Pending not computed | not computed |
5 of 6 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Apr 15, 2013 Reel 30214, frame 318 | Bergmann, Frank; Eberle, Walter; Fischer, Thomas; Von Der Eltz, Herbert | Roche Diagnostics GmbH | Assignment of Assignor's Interest |
| Apr 15, 2013 Reel 30214, frame 358 | Roche Diagnostics GmbH | Roche Diagnostics Operations, Inc. | Assignment of Assignor's Interest |
| Jan 24, 2014 Reel 32039, frame 577 | Roche Diagnostics Operations, Inc. | Roche Molecular Systems, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jul 2030
Term ends Jul 26, 2030. Maintenance fees still fall due before then
Note
The 69 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 8,445,206, US 9,347,091.
Citations
48
later US patents cite this one
That is top 10% of utility patents granted in 2016 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.